# Digoxin Products for Oral Use; Revocation of Conditions for Marketing
> **Food and Drug Administration** · Final rule. · Published 2002-06-26 · Effective 2002-07-26 · 67 FR 42992
## Document
- **Document number:** 02-16108
- **Category:** fda-drug
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 67 FR 42992
- **CFR reference:** 21 CFR 310
- **Publication date:** 2002-06-26
- **Effective date:** 2002-07-26
- **HHS docket:** Docket Nos. 76N-0080 and 00N-1610
## Abstract

The Food and Drug Administration (FDA) is revoking the regulation establishing conditions for marketing digoxin products for oral use. This regulation is no longer necessary because the products, which are new drugs, can be regulated under the approval process for new drug applications (NDAs) and abbreviated new drug applications (ANDAs) as set forth in the Federal Food, Drug, and Cosmetic Act (the act).

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2002/06/26/02-16108/digoxin-products-for-oral-use-revocation-of-conditions-for-marketing)
---
*AI Analytics · CC0 1.0*